drugset / Trial / NCT05759481

Prevention of Post-Operative Nausea and Vomiting With Propofol Infusion

NCT05759481

Phase 2 Completed 68 enrolled Milton S. Hershey Medical Center
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to clarify whether or not a low-dose propofol infusion can effectively prevent postoperative nausea and vomiting (PONV) in patients who have a documented history of PONV and/or motion sickness.

Timeline

Start
2024-02-01
Primary completion
2025-03-12
Completion
2025-03-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Propofol Small molecule 25 ug/kg Intravenous

Indications

No indication recorded.